News about "pharmaceutical company "

SIT Raids Three Bengaluru Pharmacies in Fake Medicine Probe

SIT expands its probe into an alleged fake medicine racket by examining pharmacy-level procurement and distribution links in Bengaluru.

Pharmaceutical Company | 07/10/2026 | By News Bureau

Sanofi and Cheplapharm Announce Strategic Partnership for 20 Mature Medicines and Three Sites

Sanofi and Cheplapharm plan to transfer 20 mature medicines and three manufacturing sites to Cheplapharm, with Sanofi set to receive a 26.4 percent equity stake.

Pharmaceutical Company | 16/09/2026 | By News Bureau

SK Biopharmaceuticals Secures Global Rights to Biohaven's Opakalim for Epilepsy

SK Biopharmaceuticals will gain exclusive global development and commercialisation rights to opakalim, strengthening its epilepsy portfolio alongside cenobamate and advancing its transition to a multi-product global pharma company.

Pharmaceutical Company | 27/08/2026 | By News Bureau

Qnovia Secures Global License for Novel Antimicrobial Peptide to Combat Drug-Resistant Infections

Qnovia has obtained worldwide exclusive rights from the University of Virginia to develop and commercialise the D8 antimicrobial peptide, a novel therapy designed to target multidrug-resistant bacterial infections through a unique mechanism.

Pharmaceutical Company | 31/07/2026 | By News Bureau

Newron Pharmaceuticals Secures Euro 38 Million to Advance Phase III Schizophrenia Programme

Newron Pharmaceuticals strengthens its funding base with a multi-tranche equity raise to support late-stage development of evenamide in treatment-resistant schizophrenia.

Pharmaceutical Company | 17/02/2026 | By News Bureau |  195

China's NMPA approves Almirall's Seysara for Moderate-to-Severe Acne Treatment

China’s NMPA has approved Almirall’s Seysara (sarecycline hydrochloride), the first oral antibiotic developed specifically for acne, expanding access to innovative dermatology treatment in partnership with Sinomune.

Pharmaceutical Company | 31/01/2026 | By News Bureau |  446

Asston Pharmaceuticals Secures International Supply Order Worth INR 2.65 Crore

Asston Pharmaceuticals has received an order from a leading international pharmaceutical company to supply a range of pharma products worth INR 2.65 crore

Pharmaceutical Company | 02/09/2025 | By Dineshwori |  268

Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars

Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.

Pharmaceutical Company | 18/07/2025 | By Dineshwori |  441

Samsung Bioepis Partners with Harrow for US Commercialisation of Ophthalmology Biosimilars

Following the transition of commercial rights from Biogen back to Samsung Bioepis, Harrow will assume full responsibility for the commercialisation of both BYOOVIZ and OPUVIZ biosimilars in the US.

Pharmaceutical Company | 18/07/2025 | By Dineshwori |  441

Eton Pharmaceuticals Announces Acquisition of Galzin

Galzin is FDA-approved as a maintenance treatment of patients with Wilson Disease who have been initially treated with a chelating agent.

Pharmaceutical Company | 04/01/2025 | By Aishwarya |  428